SHUBHAM DEBAJE

About

Pharmaceutical scientist by practice, I specialise in the intersection of formulation science and strategic product development. With a background spanning both industrial R&D and academic research, I help navigate the complexities of:
* Drug Delivery: Complex injectables (Liposome, Nanoparticle, Injectable Depot) & lipid-based systems.
* Strategy: Patent landscaping & data-driven research.
* Science: Solid-state pharmaceutics.
Driven by innovation and continuous learning.

Employment

• National Institute of Pharmaceutical Education and Research Doctoral Student
  2022 - Present
• Mylan India Senior Associate
  2020 - 2021
• Mylan India Associate trainee
  2019 - 2020

Education

• National Institute of Pharmaceutical Education and Research PhD
  2022 - Present
• National Institute of Pharmaceutical Education and Research M. S. (Pharm.) Pharmaceutics
  2017 - 2019
• Padmashri Doctor Vithalrao Vikhe Patil Foundation's College of Pharmacy Bachelor of Pharmacy
  2013 - 2017

Projects & Funding

Projects & funding information is unavailable.

Publications (10)

• Integrated In Silico and Experimental Insights into Immunomodulatory Toll-Like Receptor 7/8 Agonists with Anticancer Potential
  ACS Pharmacology & Translational Science 2026 DOI: 10.1021/acsptsci.6c00263
  +Save
• Mechanistic evaluation of counterion selection for lipophilic salt enabled lipid based drug delivery: a case study with acalabrutinib
  International Journal of Pharmaceutics 2026 DOI: 10.1016/j.ijpharm.2026.127200
  +Save
• Synergistic role of monoacyl phospholipids and precipitation inhibitor in ternary solid dispersions: a case study of Aripiprazole
  Drug Delivery and Translational Research 2026 DOI: 10.1007/s13346-026-02129-2
  +Save
• Supersaturated Lipid-Based Formulations of Moderately Lipophilic Neutral Drug: Impact of Formulation type, Colloidal Behaviour and Precipitation Inhibition on In Vitro-In Vivo Performance
  AAPS PharmSciTech 2026 DOI: 10.1208/s12249-026-03406-6
  +Save
• Unveiling anticancer potential of imidazo-pyridine/pyrazine-fused bicyclic heterocycles: insights from in silico and in vitro studies
  In Silico Research in Biomedicine 2026 DOI: 10.1016/j.insi.2026.100177
  +Save
• Bioanalytical method development for polmacoxib in rat plasma using LC–MS/MS and Its preclinical pharmacokinetic evaluation
  Bioanalysis 2025 DOI: 10.1080/17576180.2025.2601870
  +Save
• Advances in formulation strategies and stability considerations of amorphous solid dispersions
  Journal of Drug Delivery Science and Technology 2025 DOI: 10.1016/j.jddst.2025.106922
  +Save
• Influence of polymer and surfactant-based precipitation inhibitors on supersaturation-driven absorption of Ibrutinib from high-dose lipid-based formulations
  International Journal of Pharmaceutics 2024 DOI: 10.1016/j.ijpharm.2024.125079
  +Save
• Supersaturable diacyl phospholipid dispersion for improving oral bioavailability of brick dust molecule: A case study of Aprepitant
  European Journal of Pharmaceutics and Biopharmaceutics 2024 DOI: 10.1016/j.ejpb.2024.114241
  +Save
• Critical aspects involved in lipid dispersion and digestion: Emphasis on in vitro models and factors influencing lipolysis of oral lipid based formulations
  Advances in Colloid and Interface Science 2023 DOI: 10.1016/j.cis.2023.103028
  +Save